NCT03724877View on ClinicalTrials.gov

Effectiveness of Triple Therapy in COPD

CompletedOBSERVATIONAL
Enrollment

8,853

Participants

Timeline

Start Date

November 10, 2018

Primary Completion Date

November 12, 2018

Study Completion Date

November 12, 2018

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Long-acting beta2-agonist-long-acting muscarinic antagonists-inhaled corticosteroids(LABA-LAMA-ICS)

(LABA-LAMA-ICS)

DRUG

Long-acting beta2-agonist-inhaled corticosteroids-long-acting muscarinic antagonists (LABA-LAMA)

(LABA-LAMA)

Trial Locations (1)

E14 4PU

Clinical Practice Research Datalink, London

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY